Fritextsökning
Innehållstyper
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Orexo mot nya marknader
Smärtbehandlingen Abstral har godkänts för försäljning i Frankrike och Spanien. Det ger Orexo rätt till en milstolpeutbetalning.
-
Kombinationsläkemedel ett steg närmare lösningen
Vi ser en spännande utveckling inom bioteknik.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
How to be a perfect mingler
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Tikomed får särläkemedelsstatus
EU:s kommitté för särläkemedel har beviljat särläkemedelsstatus för preparatet Ibsolvmir. Substansen utvecklas för att förhindra avstötning vid transplantation ...
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Vart tog ljuset i tunneln vägen?
Det är mycket svårt att utveckla läkemedel mot de stora volymsjukdomarna
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Hårdare krav på godkännanden i EU än i USA?
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
LEO Pharma - International Clinical Trial Manager
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...